Assignee
NASTECH PHARM CO
US·21 granted patents·74 pending applications·581 citations·filing 1985–2009
Top patents by PatentIndex Score
95 records- 0195US7166575B2Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2002·Granted Jan 23, 2007·46 cites·19 claims
- 0293US7244709B2Compositions and methods for enhanced mucosal delivery of parathyroid hormoneNASTECH PHARM CO·Filed 2005·Granted Jul 17, 2007·26 cites·32 claims
- 0391US7157426B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Jan 2, 2007·40 cites·19 claims
- 0488US6451848B1Compositions and methods comprising morphine gluconateNASTECH PHARM CO·Filed 2000·Granted Sep 17, 2002·27 cites·21 claims
- 0586US7863245B2Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesityNASTECH PHARM CO·Filed 2008·Granted Jan 4, 2011·6 cites·15 claims
- 0686US7186691B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2003·Granted Mar 6, 2007·22 cites·27 claims
- 0784US7229966B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Jun 12, 2007·20 cites·41 claims
- 0884US6677346B1Methods comprising intranasal morphineNASTECH PHARM CO·Filed 2000·Granted Jan 13, 2004·33 cites·13 claims
- 0982US7186692B2Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Mar 6, 2007·15 cites·50 claims
- 1082US6436950B1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 1999·Granted Aug 20, 2002·46 cites·15 claims
- 1181US6599883B1Nasal delivery of xylitolNASTECH PHARM CO·Filed 1999·Granted Jul 29, 2003·58 cites·26 claims
- 1281US6225343B1Compositions and methods comprising morphine gluconateNASTECH PHARM CO·Filed 1999·Granted May 1, 2001·43 cites·37 claims
- 1379US7229636B1Cyanocobalamin low viscosity aqueous formulations for intranasal deliveryNASTECH PHARM CO·Filed 2004·Granted Jun 12, 2007·10 cites·31 claims
- 1479US4778810ANasal delivery of caffeineNASTECH PHARM CO·Filed 1987·Granted Oct 18, 1988·73 cites·8 claims
- 1577US6740660B2Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2002·Granted May 25, 2004·6 cites·12 claims
- 1676US4749700ANovel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing sameNASTECH PHARM CO·Filed 1987·Granted Jun 7, 1988·56 cites·19 claims
- 1769US2007155658A1Nanoparticles for delivery of nucleic acids and stable double-stranded rnaNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 1868US2009274658A1Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic CompoundsNASTECH PHARM CO·Filed 2009·Application pending·0 cites
- 1965US2005136437A1Nanoparticles for delivery of nucleic acids and stable double-stranded RNANASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2064US7329725B1Phage displayed Trp cage ligandsNASTECH PHARM CO·Filed 2004·Granted Feb 12, 2008·0 cites·28 claims
- 2164US2006122137A15'-methylpyrimidine and 2'-O-methyl ribonucleotide modified double-stranded ribonucleic acid moleculesNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 2263US4624965ANovel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing sameNASTECH PHARM CO·Filed 1985·Granted Nov 25, 1986·30 cites·7 claims
- 2363US2004242626A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2463US2008113011A1Compositions and methods for enhanced mucosal delivery of interferon betaNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 2563US2008261304A1Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cellsNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 2663US2004204441A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2763US2004242625A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 2861US2006160123A1Method of minimizing off-target effects of siRNA moleculesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 2961US2006210614A1Method of treatment of a metabolic disease using intranasal administration of exendin peptideNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3061US2007154449A1Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3160US2007244049A1Compositions and methods for enhanced mucosal delivery of parathyroid hormoneNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 3260US2005129679A1Method for opening tight junctionsNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 3360US2006142230A1Double-stranded ribonucleic acid molecules having ribothymidineNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 3458US2007129299A1Compositions and methods for enhanced mucosal delivery of pyy peptideNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3558US2007275893A1Compositions for enhanced epithelial permeation of peptide yy for treating obesityNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3658US2007197437A1Compositions for enhanced epithelial permeation of y2 receptor-binding peptidesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3757US2007185035A1Enhanced mucosal administration of neuroprotective peptidesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3857US2006003989A1Compositions and methods using acetylcholinesterase (ACE) inhibitors to treat central nervous system (CNS) disorders in mammalsNASTECH PHARM CO·Filed 2005·Application pending·0 cites
- 3957US2005143303A1Intranasal administration of glucose-regulating peptidesNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 4056US2004258663A1Compositions and methods for enhanced mucosal delivery of interferon alphaNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 4156US2007213257A1Compositions and methods for complexes of nucleic acids and peptidesNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4256US2007293449A1Compositions and methods for delivery of double-stranded rnaNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4356US2007173447A1Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agentNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4456US2008234200A1Method of treatment of a metabolic disease using intranasal administration of exendin peptideNASTECH PHARM CO·Filed 2008·Application pending·0 cites
- 4556US2007213293A1Rnai therapeutic for respiratory virus infectionNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4656US2007077283A1Method of enhancing transmucosal delivery of therapeutic compoundsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 4756US2008119408A1Pth formulations for intranasal deliveryNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4855US2004242624A1Nasal delivery of apomorphineNASTECH PHARM CO·Filed 2004·Application pending·0 cites
- 4955US2007172430A1Dry powder compositions for rna influenza therapeuticsNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 5055US2004248846A1Intranasal administration of triptansNASTECH PHARM CO·Filed 2004·Application pending·0 cites
Showing the top 50 of 95 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →